[Retracted] The Number of Intraoperative Intestinal Venous Circulating Tumor Cells Is a Prognostic Factor for Colorectal Cancer Patients

Table 8

Multivariate analysis of OS in patients with CRC.

Variable	β	Se	Wald χ2	Exp (B)	95% CI	P-value
Gender	0.995	0.621	2.369	2.599	[0.770, 8.774]	0.124
Age/years	−1.122	0.776	2.090	0.326	[0.071, 1.491]	0.148
Tumor location	0.129	1.014	0.016	1.137	[0.156, 8.300]	0.899
Histologic differentiated	−1.097	0.685	2.564	0.334	[0.087, 1.279]	0.109
Diameter/cm	−0.557	0.845	0.434	0.573	[0.109, 3.004]	0.510
Invasion depth	−2.113	1.259	2.818	0.121	[0.010, 1.425]	0.093
Lymph node metastasis	0.219	1.017	0.047	1.245	[0.170, 9.135]	0.829
TNM staging	2.553	1.140	5.015	12.847	[1.375, 119.998]	0.025
AFP/(ng/ml)	−1.233	0.857	2.069	0.292	[0.054, 1.564]	0.150
CEA/(ng/ml)	1.577	1.062	2.205	4.841	[0.604, 38.818]	0.138
CA19-9/(U/ml)	1.375	0.894	2.364	3.956	[0.685, 22.837]	0.124
CA72-4/(U/ml)	−0.984	1.058	0.865	0.374	[0.047, 2.973]	0.352
CA-125 (U/ml)	−3.365	1.307	6.630	0.035	[0.003, 0.448]	0.010
CTCs (n/3.2 ml)	−3.813	1.239	9.467	0.022	[0.002, 0.251]	0.001
KRAS	2.235	0.880	6.447	9.346	[1.665, 52.459]	0.011

CTCs, circulating tumor cells; AFP, alpha-fetoprotein; CEA, carcinoembryonic antigen; CA19-9, glycoprotein antigen 199; CA-125, glycoprotein antigen 125; CA72-4, glycoprotein antigen 72-4; KRAS, Kirsten rat sarcoma virus oncogene.